Currently out of the existing stock ratings of John Young, 19 are a HOLD (35.85%), 34 are a BUY (64.15%).
Analyst John Young, currently employed at CANACCORD, has had 35.05% of price targets met with an average potential upside of 26.15%, reached in 80 days on average.
John Young has documented 105 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ANGO, AngioDynamics at 09-Oct-2026.
Analyst best performing recommendations are on STAA (STAAR SURGICAL COMPANY).
The best stock recommendation documented was for STAA (STAAR SURGICAL COMPANY) on 2/27/2024. The price target of $32 was fulfilled within 1 day with a profit of $0.68 (2.08%), with a performance score of 20.81.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 26-Oct-2020
$4
$1.43 (55.64%)
$5
24 days ago
(28-Oct-2026)
1/7 (14.29%)
$1.48 (58.73%)
29
Buy Since 10-Mar-2025
$14
$12.75 (1020.00%)
6 months 22 days ago
(30-Apr-2026)
0/3 (0%)
$12.72 (993.75%)
Buy Since 31-Oct-2023
$5
$3.75 (300.00%)
$15
8 months 16 days ago
(05-Mar-2026)
1/8 (12.5%)
$3.39 (210.56%)
43
Buy Since 04-Jun-2024
$4
$12
1 years 24 days ago
(28-Oct-2025)
0/2 (0%)
$2.02 (102.02%)
Buy Since 10-Dec-2021
$2.5
1 years 3 months 21 days ago
(31-Jul-2025)
4/12 (33.33%)
$0.66 (35.87%)
92
Which stock is John Young most bullish on?
What Year was the first public recommendation made by John Young?